InMed Pharmaceuticals Inc. Gains 28.57%
Thu, Sep 01, 2022 at 07:14 PM
InMed Pharmaceuticals Inc. (INM:NASDAQ) soared at $0.31, representing a gain of 28.6%. On Thu, Sep 01, 2022, INM:NASDAQ touched a New 2-Week Intraday Low of $0.23. The stock appeared on our News Catalysts scanner on Tue, Aug 23, 2022 at 05:25 PM in the 'SPLIT' category. From Thu, Aug 18, 2022, the stock recorded 30.00% Up Days and 9.09% Green Days
The stock spiked on Thu, Apr 21, 2022 at $1.42 with a volume of 4M+.
About InMed Pharmaceuticals Inc. (INM:NASDAQ)
InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company.
Top 10 Gainers:
- Hempacco Co. Inc. (HPCO:NASDAQ), 63.41%
- GigaCloud Technology Inc (GCT:NASDAQ), 61.43%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 58.69%
- Forma Therapeutics Holdings Inc. (FMTX:NASDAQ), 51.04%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- ShiftPixy, Inc. (PIXY:NASDAQ), 46.9%
- Shuttle Pharmaceuticals Holdings Inc. (SHPH:NASDAQ), 36.17%
- Kuke Music Holding Limited American Depositary Shares each representing one (KUKE:NYSE), 32.94%
- Nutanix, Inc. (NTNX:NASDAQ), 29.13%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 28.57%